Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What Are the Forecasted Growth Rate and Market Size of the Gene Therapy Clinical Trial Services Market?#_x000D_
The market size for clinical trial services in gene therapy has seen a significant expansion in the past few years. It is predicted to expand from a value of $1.53 billion in 2024 to reach $1.82 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 19.6%. Factors such as an increase in research and development investment, the rising occurrence of rare genetic disorders, the trend towards precision medicine approaches, enhanced regulatory support through fast-track approval routes, and a growth in gene therapy candidates have all contributed to this historical growth._x000D_
_x000D_
Rapid expansion is projected for the gene therapy clinical trial services market in the coming years, with its value set to escalate to $3.69 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 19.2%. This progressive uplift during the forecast period is due to factors such as advancements in gene-editing technology, an increase in clinical trials, heightened demand for tailored treatment, increased investment in cell and gene therapy manufacturing infrastructure, and a surge in efforts to recruit patients. The period is also expected to see emerging trends including improvements in gene-editing methods, enhancements in vector manufacturing capabilities, developments in patient recruitment tactics, real-world evidence integration, and the incorporation of a decentralized trial model._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp_x000D_
_x000D_
#Which Factor Is Shaping The Future Of The Gene Therapy Clinical Trial Services Market?#_x000D_
The surge in personalized medicine is predicted to catalyze the expansion of the gene therapy clinical trial services market. Personalized medicine is a methodology that customizes medical treatment based on various individual factors such as genetics, biomarkers, and lifestyle aspects. Developments in genomics and biotechnology, leading to more accurate therapy targeting, have caused a rise in the demand for personalized medicine. Gene therapy clinical trial services further aid personalized medicine by examining individual genetic profiles and tailoring treatment plans. They utilize biomarker assessment and companion diagnostics to improve therapy for each person, thereby boosting safety and effectiveness. In February 2024, the Personalized Medicine Coalition, a healthcare organization based in the US, reported that the FDA had approved 16 fresh personalized treatments in 2023 for patients with rare diseases, a substantial increase from only six in 2022. Consequently, the escalating demand for personalized medicine is fueling the growth of the gene therapy clinical trial services market._x000D_
_x000D_
#What Is The Segment-Wise Breakdown Of The Gene Therapy Clinical Trial Services Market?#_x000D_
The gene therapy clinical trial services market covered in this report is segmented_x000D_
_x000D_
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types_x000D_
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications_x000D_
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)_x000D_
_x000D_
Subsegments:_x000D_
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design_x000D_
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage_x000D_
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring_x000D_
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling_x000D_
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits_x000D_
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention_x000D_
_x000D_
#Which Trends Are Redefining The Future Landscape Of The Gene Therapy Clinical Trial Services Industry?#_x000D_
Major corporations in the gene therapy clinical trial services industry are now focusing on creating inventive solutions such as the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials. These developments aim to speed up the entire trial process while still maintaining safety and regulatory standards. A Long-Term Follow-Up (LTFU) model for CGT trials is a structured plan to observe patients for a prolonged period, often up to 15 years post the CGT treatment. Medable Inc., a U.S.-based SaaS company, is an example of a company that launched a digital-first LTFU model for CGT trials in May of 2025. This initiative backs CGT trials by lessening the patient’s and site’s burdens, ensuring scientific accuracy over the required FDA 15-year monitoring period. It enhances the access of patients, their retention, and the continuity of data through remote and hybrid follow-up methods, thus amplifying long-term safety and efficiency monitoring._x000D_
_x000D_
#Which Companies Hold The Largest Market Share In The Gene Therapy Clinical Trial Services Sector?#_x000D_
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#How Does Regional Performance Compare Across The Gene Therapy Clinical Trial Services Industry?#_x000D_
North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model